rucaparib for relapsed ovarian cancer: safety profile
Published 4 years ago • 264 plays • Length 2:58Download video MP4
Download video MP3
Similar videos
-
4:25
rucaparib: clinical activity in relapsed ovarian cancer
-
4:20
rucaparib explored for high-risk ovarian cancer
-
5:11
defining rucaparib’s value in recurrent ovarian cancer
-
2:07
rucaparib in platinum-sensitive ovarian cancer
-
3:11
rucaparib in recurrent ovarian cancer: ariel3 trial
-
1:34
dr. kristeleit on the safety profile of rucaparib in ovarian cancer
-
2:15
toxicities associated with rucaparib for the treatment of ovarian cancer
-
6:12
rucaparib for recurrent ovarian cancer
-
0:52
dr. mirza on safety profile of niraparib/bevacizumab in recurrent ovarian cancer
-
1:21
rucaparib may improve pfs in patients with ovarian cancer
-
3:06
rucaparib maintenance therapy for high-risk ovarian cancer
-
1:41
the clinical activity of rucaparib in patients with ovarian cancer
-
1:42
phase iii results for rucaparib in ovarian cancer
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
6:49
platinum-sensitive relapsed ovarian cancer: rucaparib
-
5:17
outlook for patients with high-risk ovarian cancer
-
3:29
rucaparib boosts pfs in brca-mutated recurrent ovarian cancer
-
1:36
dr. coleman discusses the toxicities associated with rucaparib in patients with ovarian cancer
-
4:31
maintenance therapy for advanced ovarian cancer